Navigation Links
Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
Date:11/3/2009

NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Chinese Markets for Bladder Cancer Treatment Drugs

http://www.reportlinker.com/p0157401/Chinese-Markets-for-Bladder-Cancer-Treatment-Drugs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology

Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators

Industrial Output

Population and Labor

Foreign Investment

Foreign Trade

Financial and Tax Regulations

Banking System and Regulations

Foreign Exchange

Taxes, Tariff and Custom Duties

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Bladder Cancer Treatment Drugs Industry Structure

Market Size

Market Growth Drivers

Bladder Cancer Treatment Drugs Sales Volume

Major Producer Facility Locations

Major Producers' Sales Volume and Market Share

Labor Cost

Potential Entrants

Major Distributors

Major Foreign Investment

Technology Development

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Bladder Cancer Overview

Bladder Cancer Treatment Drugs Market Overview

Bladder Cancer Treatment Drugs Market Overview by Classification

Intraluminal Perfusion Agents

Unilateral Chemotherapy Drug

First-line Chemotherapy Drug

Immunomodulator

Other Drugs

Bladder Cancer Treatment Drugs Import and Export by Classification

Bladder Cancer Treatment Drugs Import

Bladder Cancer Treatment Drugs Export

Market Overview by Drug's Active Principle

Market Overview by Producers

Pricing Trend

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

Bladder Cancer Treatment Drugs Markets Outlook Overview

Government Regulation

Health Care Insurance Industry Overview

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview

China's Distribution System

Bladder Cancer Treatment Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications

China's Market Entry

Export to China

Indirect export

Direct Export

License and Contract Manufacture

Assembling in China

Contract Manufacturing

Trade Permit

Investment

Equity Joint Venture

Contractual Joint Venture

Wholly Foreign-Owned Enterprise

VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Profiles of Bladder Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators

Industrial Output

Population and Labor Force Trends

Foreign Investment and Loans

Foreign Trade

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share in 2008

Bladder Cancer Treatment Drugs Sales Volume

Major Producer Facility Location

Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share in 2008

Major Foreign Investment in China

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Bladder Cancer Treatment Drugs Import by Country in 2008

Bladder Cancer Treatment Drugs Export by Country in 2008

Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification

Bladder Cancer Treatment Drugs Import by Drugs Classification

Bladder Cancer Treatment Drugs Export by Drugs Classification

Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share in 2008

Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share in 2008

Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share in 2008

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

Bladder Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China's GDP and Growth Rate

Industrial Output by Ownership

China's Imports and Exports

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Bladder Cancer Treatment Drugs Sales Volume

Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008

Top 14 Bladder Cancer Treatment Drugs Market Share in 2008

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Bladder Cancer Treatment Drugs Sales Volume

Bladder Cancer Treatment Drugs Import

Bladder Cancer Treatment Drugs Import by Country in 2008

Bladder Cancer Treatment Drugs Export

Bladder Cancer Treatment Drugs Export by Country in 2008

Bladder Cancer Treatment Drugs Sales Volume by Classification in 2008

Intraluminal Perfusion Agents Sales Volume and Market Share

Unilateral Chemotherapy Drug Sales Volume and Market Share

First-Line Chemotherapy Drug Sales Volume and Market Share

Immunomodulator Sales Volume and Market Share

Other Drugs Sales Volume and Market Share

Bladder Cancer Treatment Drugs Import by Classification in 2008

Unilateral Chemotherapy Drug Import and Market Share

First-Line Chemotherapy Drug Import and Market Share

Intraluminal Perfusion Agents Import and Market Share

Immunomodulator Import and Market Share

Other Drugs Import and Market Share

Bladder Cancer Treatment Drugs Export by Drugs Classification in 2008

Unilateral Chemotherapy Drug Export and Market Share

First-Line Chemotherapy Drug Export and Market Share

Intraluminal Perfusion Agents Export and Market Share

Immunomodulator Export and Market Share

VI. MARKETING STRATEGIES

China's Distribution Channel

To order this report:

Chinese Markets for Bladder Cancer Treatment Drugs

http://www.reportlinker.com/p0157401/Chinese-Markets-for-Bladder-Cancer-Treatment-Drugs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , February 23, 2017 ... market: the Berlin office was ... Magdalena Kritikos . The portfolio includes Entocort ® ... for the treatment of ulcerative colitis, and VistaPrep ® ... solutions, the Swiss specialty pharmaceutical company focused on the ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady ... Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills ... liability and other personal injury cases. These injuries have a major impact on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Using the ... leads utilizing a simple online checklist. Over a period of just 24 months, thousands ... assistance of an online checklist called T.A.D. , “The internet is not getting quieter. ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for ... help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for ... and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized ...
Breaking Medicine News(10 mins):